Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Newron Pharmaceuticals to Present at the JMP Securities Life Sciences Conference


Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced that Stefan Weber, CEO, will be participating on a panel discussion entitled, "Innovative Treatment Approaches to Orphan CNS Developmental Disorders" at the JMP Securities Life Sciences Conference on Wednesday, June 19th, 2019 at 10:00 a.m. EDT. The panel will focus on novel pharmacological approaches to treating orphan genetic disorders that primarily impact the central nervous system.

About Newron Pharmaceuticals
Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The company is headquartered in Bresso near Milan, Italy. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson's disease in the European Union, Switzerland, the US, Australia, Canada, Brazil, and Colombia and is commercialized by Newron's partner Zambon. US WorldMeds holds the commercialization rights in the USA. Meiji Seika has the rights to develop and commercialize the compound in Japan and other key Asian territories. In addition to Xadago® for Parkinson's disease, Newron has a strong pipeline of promising treatments for rare disease patients at various stages of clinical development, including sarizotan for patients with Rett syndrome and ralfinamide for patients with specific rare pain indications. Newron is also developing Evenamide as the potential first add-on therapy for the treatment of patients with positive symptoms of schizophrenia. For more information, please visit: www.newron.com


These press releases may also interest you

at 00:00
White Oaks Wealth Advisors is pleased to announce their listing in Financial Advisor Magazine's 2019 RIA Survey and Ranking. The list recognizes top independent RIA firms from across the U.S. To be eligible for this ranking, firms must be independent...

20 jui 2019
Fifty years to the day that astronauts Neil Armstrong and Buzz Aldrin stepped on the Moon in a giant leap for humanity, NASA astronaut Andrew Morgan and two fellow crew members arrived Saturday for their mission aboard the International Space...

20 jui 2019
NASA commercial cargo provider SpaceX now is targeting 6:24 p.m. EDT Wednesday, July 24, for the launch of its 18th resupply mission to the International Space Station. Live coverage will begin on NASA Television and the agency's website with...

20 jui 2019
13 July Guangzhou, Qianze Asset Management Limited, a Chinese investment firm specializing in artificial intelligence (AI) based trading strategies held its inaugural BDAI seminar at the Sun Yat-Sen University last Saturday. The seminar, which was...

20 jui 2019
Vice President Mike Pence visited and gave remarks in the Neil Armstrong Operations and Checkout Building at NASA's Kennedy Space Center in Florida on Saturday to commemorate the 50th anniversary of the agency's Apollo 11 Moon landing and announce to...

20 jui 2019
The goal of humans again walking on the Moon is one giant leap closer. Lockheed Martin has completed building the capsule for NASA's Orion spacecraft. The crew module capsule for the uncrewed Artemis 1 mission to the Moon has been stacked on top of...



News published on 13 june 2019 at 07:05 and distributed by: